Amgen Regeneron

ADA preview: 5 things to watch in diabetes
BioPharma Dive
Sun, 06/11/17 - 09:30 am
ADA
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Lantus
Tresiba
JNJ
Novo Nordisk
PCSK9 inhibitors
Amgen Regeneron
Sanofi
Apple
Google
insulin